Wedbush Reiterates Outperform Rating on BridgeBio Oncology Therapeutics, In (BBOT)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: BBOT) | Delayed: 2.66 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.66 | 52 Week High | $ | |||
| Open | $2.66 | 52 Week Low | $ | |||
| Day High | $2.66 | P/E | N/A | |||
| Day Low | $2.66 | EPS | $ | |||
| Volume | 1 | |||||
